Market News (Page 39) - TendieTensor

Market News Page 39 of 276 • 6,884 articles

ASML Holds Premium Valuation as Semiconductor Capex Momentum Carries Into 2026

Investing.com • Itai Smidt

ASML Holds Premium Valuation as Semiconductor Capex Momentum Carries Into 2026

12/29/2025 03:51 PM • ASML trades at $1,066 with a 37.4x P/E multiple, justified by its near-monopoly in EUV lithography and strong semiconductor capex growth expected through 2026. While China revenue normalization poses a near-term headwind, core customers like TSMC, SK hynix, and Micron are projected to grow capex 18-19% in 2026, supporting mid-single-digit to low double-digit revenue growth. The stock deserves a Buy rating with 16-17% upside to fair value over 12-24 months.

GDXU - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
ASML - ASML maintains a strong competitive moat with its near-monopoly in advanced EUV and High-NA lithography systems. Despite a premium 37.4x P/E valuation, the company is supported by robust semiconductor capex growth (11-19% for core customers in 2026), high FCF margins (27.7%), and limited competitive threats. The stock offers 16-17% upside to fair value with manageable risks.

#ASML #semiconductor equipment #EUV lithography #capex cycle #High-NA EUV #China export restrictions #AI infrastructure spending #TSMC #Samsung #Intel #Micron #SK hynix

GlobeNewswire Inc. • Na

Changes in company's own shares

12/29/2025 02:40 PM • Alvotech announced the European launch of AVT05, its first-in-market biosimilar to Simponi (golimumab), in partnership with Advanz Pharma. The launch is supported by an NHS England tender award in the United Kingdom. The company also published its 2026 financial calendar.

FNGU - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
ALVO - Company achieved a significant milestone with the European launch of its first-in-market biosimilar, supported by NHS England tender award, indicating market validation and commercial progress.

#biosimilar #AVT05 #Simponi #golimumab #European launch #NHS England #Advanz Pharma #financial calendar

GlobeNewswire Inc. • Na

Breyting á fjölda eigin hluta

12/29/2025 02:40 PM • Alvotech announced the European launch of AVT05, its first-in-market biosimilar to Simponi (golimumab), through partner Advanz Pharma. The launch is supported by an NHS England tender award in the United Kingdom. The company also published its financial calendar for 2026.

FNGS - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
ALVO - The company achieved a significant milestone with the European launch of its first-in-market biosimilar, supported by an NHS England tender award, which validates market demand and provides competitive advantage in the biosimilar space.

#biosimilar #AVT05 #Simponi #golimumab #European launch #NHS England #Advanz Pharma

This Energy Stock Fell 11% in a Year, but One Fund Is Betting $169 Million on Its Performance

The Motley Fool • Jonathan Ponciano

This Energy Stock Fell 11% in a Year, but One Fund Is Betting $169 Million on Its Performance

12/29/2025 02:30 PM • Denver-based Sourcerock Group significantly increased its stake in California Resources Corporation (CRC) by 1.18 million shares in Q3, bringing its total holding to 3.18 million shares valued at $169.14 million. Despite CRC's 11% decline over the past year, the fund's conviction bet reflects confidence in the company's strong cash flow generation, with Q3 operating cash flow of $279 million and a 5% dividend increase, positioning it as a resilient energy play for patient capital.

GDXD - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
CRC - Despite a 11% stock price decline over the past year, the company demonstrates strong fundamentals with $279 million in Q3 operating cash flow, $188 million in free cash flow, a 5% dividend increase, and $1.15 billion in liquidity. A major institutional fund's $169 million investment increase signals confidence in its cash generation and resilience, positioning it as a valuable long-term holding for patient investors seeking cash flow stability in the energy sector.

#California Resources Corporation #energy stock #institutional investment #cash flow #dividend #oil and gas #Sourcerock Group

Deadline Alert: Alexandria Real Estate Equities, Inc. (ARE) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: Alexandria Real Estate Equities, Inc. (ARE) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

12/29/2025 01:36 PM • Alexandria Real Estate Equities (ARE) faces a securities fraud class action lawsuit after missing Q3 2025 earnings estimates and cutting full-year guidance. The company disclosed a $323.9 million real estate impairment charge, with $206 million attributed to its Long Island City property. The stock fell 19.2% on October 28, 2025. Investors are urged to file lead plaintiff motions by January 26, 2026.

FLYU - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
ARE - The company missed consensus earnings estimates, cut full-year FFO guidance, disclosed a $323.9 million impairment charge, and experienced a 19.2% stock price decline. Additionally, allegations of materially false statements regarding the Long Island City property's value and occupancy stability form the basis of the securities fraud lawsuit.

#securities fraud #class action lawsuit #earnings miss #impairment charge #Long Island City #stock decline #investor losses

Deadline Alert: F5, Inc. (FFIV) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: F5, Inc. (FFIV) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

12/29/2025 01:35 PM • F5, Inc. faces a class action securities fraud lawsuit after failing to disclose a significant nation-state security breach that compromised BIG-IP source code and undisclosed vulnerabilities. The breach, revealed on October 15, 2025, led to a 10.7% stock decline, followed by another 7.8% drop when the company issued weak fiscal 2026 guidance citing remediation costs and reduced sales expectations. Investors have until February 17, 2026 to file lead plaintiff motions.

FNGD - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
FFIV - F5 is the subject of a securities fraud lawsuit alleging material misstatements and failure to disclose a significant security breach. The breach compromised sensitive source code and vulnerabilities, resulting in substantial stock price declines (18.5% total) and weak forward guidance due to remediation costs and reduced sales expectations.

#securities fraud #class action lawsuit #security breach #nation-state threat actor #source code exfiltration #stock price decline #undisclosed vulnerabilities #remediation costs

Deadline Alert: Perrigo Company plc (PRGO) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: Perrigo Company plc (PRGO) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

12/29/2025 01:32 PM • Glancy Prongay & Murray LLP is alerting Perrigo Company plc investors about a securities fraud class action lawsuit with a January 16, 2026 deadline to file as lead plaintiff. The lawsuit alleges that Perrigo made materially false statements regarding its acquisition of Nestlé's infant formula business, failing to disclose significant underinvestment, manufacturing deficiencies, and the need for substantial remediation costs exceeding initial estimates. The company's stock fell significantly on multiple occasions (15.14%, 9.8%, 11.31%, and 25.2%) as it repeatedly revised guidance downward and announced a strategic review of the infant formula business.

FNGO - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
PRGO - The company is the subject of a securities fraud lawsuit alleging material misstatements and omissions regarding its infant formula business acquisition. Multiple significant stock price declines (totaling over 50% from peak to trough during the class period), repeated downward guidance revisions, and disclosure of substantial undisclosed remediation costs and manufacturing issues indicate serious operational and financial problems, along with potential investor deception.

#securities fraud #class action lawsuit #infant formula business #Nestlé acquisition #misstatements #manufacturing deficiencies #remediation costs #stock decline #guidance revision

94% of Engineering Leaders Report Agentic AI Skills Gaps as Autonomous Systems Move Into Production - Interview Kickstart Launches New Agentic AI Course for Engineers 2026

GlobeNewswire Inc. • Interview Kickstart

94% of Engineering Leaders Report Agentic AI Skills Gaps as Autonomous Systems Move Into Production - Interview Kickstart Launches New Agentic AI Course for Engineers 2026

12/29/2025 12:52 PM • The agentic AI market has rapidly moved from experimentation to production deployment in 2025, creating critical skills shortages across engineering organizations. 94% of engineering leaders report gaps in agentic AI expertise, with 41% of organizations planning deployment within six months. The global agentic AI market is projected to grow from $7.38 billion in 2025 to $47 billion by 2030. Interview Kickstart has launched a 14-week Agentic AI Career Boost program to address the skills gap across multiple engineering disciplines.

CARD - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
AMZN - Amazon is mentioned only in the context of AI-driven tech layoffs reshaping careers. While this indicates workforce restructuring, the article does not provide specific details about Amazon's agentic AI initiatives or market position, warranting a neutral stance.

#agentic AI #skills gap #autonomous systems #production deployment #engineering leadership #multi-agent systems #upskilling #market growth #infrastructure engineering #DevOps

GlobeNewswire Inc. • Na

Transaction in Own Shares

12/29/2025 12:38 PM • Shell plc purchased 1,486,298 shares for cancellation on 29 December 2025 across multiple trading venues (LSEG and XAMS), as part of its existing share buyback programme authorized through 30 January 2026. The purchases were executed by Merrill Lynch International within pre-set parameters in compliance with UK and EU market abuse regulations.

CARU - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
SHEL - The share buyback is a routine capital allocation activity that demonstrates confidence in the company's financial position and commitment to shareholder returns. However, it is a standard corporate action without material news impact, hence neutral sentiment rather than positive.

#share buyback #share repurchase #share cancellation #LSEG #XAMS #Merrill Lynch International #market abuse regulation #shareholder returns

Is Micron Technology a Good Value in this Economy?

The Motley Fool • James Hires

Is Micron Technology a Good Value in this Economy?

12/29/2025 12:35 PM • Micron Technology is presented as an undervalued AI hardware play, specifically in computer memory chips. Despite the S&P 500 trading at historically high valuations (P/E of 30), Micron offers attractive value with a trailing P/E of 22.8, 57% revenue growth, and 167% EPS growth. The company is positioned to benefit from AI-driven memory shortages, with the memory chip market growing 88% in 2024. Micron has outperformed the broader market by over 200% in the past year.

FLYD - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
MU - Company is highlighted as undervalued with strong fundamentals: low P/E ratio (22.8) relative to peers and S&P 500, exceptional revenue growth (57%), significant EPS growth (167%), healthy gross margins (57%), and positioned to capitalize on AI-driven memory shortage. Stock has outperformed market significantly (+200% YoY).

#artificial intelligence #computer memory #semiconductor #valuation #AI hardware shortage #memory chips #data centers

Verizon: Out of the Doghouse and Into Your Dividend Portfolio

Investing.com • Thomas Hughes

Verizon: Out of the Doghouse and Into Your Dividend Portfolio

12/29/2025 12:35 PM • Verizon, the 2025 Dogs of the Dow leader with a 6.8% dividend yield, is positioned for strong 2026 performance. Trading at historically low valuations (8.5X earnings vs. 10-year average of 12X), the company is expected to rise at least 17% with potential for 20% upside. Key catalysts include cost-cutting initiatives, 5G and IoT growth, debt reduction, and potential share buybacks. Verizon is on track to achieve Dividend Aristocrat status within four years.

DULL - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
VZ - Verizon is highlighted as undervalued with a historically low P/E ratio of 8.5X, strong dividend yield of nearly 7%, and multiple growth catalysts including 5G/IoT expansion, cost efficiency improvements, and potential for 17-20% share price appreciation in 2026. The company's focus on debt reduction and upcoming Dividend Aristocrat status further support a positive outlook.

#Dogs of the Dow #dividend yield #5G #IoT #cost-cutting #debt reduction #share buybacks #Dividend Aristocrat #valuation

HEYTEA Partners with POP MART’s Twinkle Twinkle for First Global Simultaneous Launch

GlobeNewswire Inc. • Na

HEYTEA Partners with POP MART’s Twinkle Twinkle for First Global Simultaneous Launch

12/29/2025 11:57 AM • HEYTEA and POP MART launched their first globally synchronized co-branded campaign featuring the Twinkle Twinkle IP across December 22, spanning over 100 stores worldwide including China, Hong Kong, Macao, and international markets in the US, UK, and Canada. The collaboration includes custom character designs, co-branded drinks, themed merchandise, and pop-up activations, reflecting HEYTEA's strategy of using localized, culturally relevant partnerships to build international presence while maintaining global brand coherence.

BMO - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
PMRTY - POP MART's Twinkle Twinkle IP is being leveraged in a major global co-branded campaign with HEYTEA, demonstrating strong IP value and market appeal. The collaboration spans multiple regions and generates significant social media attention, indicating successful IP monetization and brand partnership opportunities.

#HEYTEA #POP MART #Twinkle Twinkle #co-branded campaign #global expansion #tea beverages #seasonal collaboration #international markets #product innovation #pop-up activation

Societe Generale: Information regarding executed transactions within the framework of a share buy-back programme

GlobeNewswire Inc. • Na

Societe Generale: Information regarding executed transactions within the framework of a share buy-back programme

12/29/2025 11:46 AM • As of 26 December 2025, Societe Generale has repurchased 1.3% of its capital and completed 61.4% of its previously announced EUR 1 billion share buy-back programme. During the period of 22-26 December 2025, the bank purchased 716,800 shares across multiple markets at a daily weighted average price of €67.77 per share.

BNKD - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
SCGLY - The company is actively executing its announced share buy-back programme, having completed over 61% of the EUR 1 billion commitment. Share buy-backs are generally viewed positively as they can support stock prices, reduce share count, and signal management confidence in the company's valuation and financial position.

#share buy-back #capital repurchase #EUR 1 billion #shareholder returns #equity transactions

Melexis: update over het aandeleninkoopprogramma

GlobeNewswire Inc. • Na

Melexis: update over het aandeleninkoopprogramma

12/29/2025 11:45 AM • Melexis announced the purchase of 11,600 shares on Euronext Brussels between December 22-24, 2025, at an average price of €56.64 per share, totaling €656,972. Under the current buy-back program for up to 850,000 shares, Melexis has now acquired 40,200 shares, bringing total treasury shares to 871,691 when combined with previous programs.

BULZ - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
MLXSY - The share buy-back is a routine capital allocation activity that demonstrates confidence in the company's valuation and financial position. However, it is neither inherently positive nor negative as it represents a neutral corporate action with no material business impact disclosed.

#share buy-back #treasury shares #Euronext Brussels #capital allocation #shareholder returns

Melexis: update on the share buy-back program

GlobeNewswire Inc. • Na

Melexis: update on the share buy-back program

12/29/2025 11:45 AM • Melexis completed the purchase of 11,600 shares between December 22-26, 2025, as part of its announced share buy-back program. The company acquired shares at an average price of €56.64, bringing total treasury shares held to 871,691 shares under current and previous buy-back programs.

BNKU - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
MLXSY - The share buy-back is a routine capital allocation activity that demonstrates confidence in the company's valuation and commitment to shareholder returns. However, it is a neutral event as it neither indicates significant business growth nor operational challenges. The consistent execution of the announced program at stable prices reflects normal corporate operations.

#share buy-back #treasury shares #Euronext Brussels #capital allocation #shareholder returns

New career development Book from Palmetto Publishing titled HIRED! Gives Job Seekers a Proven, Step-by-Step Playbook to Land the Job They Want.

GlobeNewswire Inc. • Victoria Feldman And Tatiana Topiol Kimron

New career development Book from Palmetto Publishing titled HIRED! Gives Job Seekers a Proven, Step-by-Step Playbook to Land the Job They Want.

12/29/2025 11:00 AM • Career coaches Victoria Feldman and Tatiana Topiol Kimron have published 'HIRED!', a job search guide based on their experience at major tech companies. The book provides practical strategies to help job seekers stand out in competitive markets, prepare for interviews, and secure positions that align with their goals.

AMZN - Mentioned as a past employer of co-author Victoria Feldman, demonstrating her experience in talent development at major tech companies. No positive or negative business implications are discussed.

#career development #job search #hiring strategies #career coaching #tech industry #interview preparation

FLY Investors Have Opportunity to Lead Firefly Aerospace Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • Schall Law Firm

FLY Investors Have Opportunity to Lead Firefly Aerospace Inc. Securities Fraud Lawsuit with the Schall Law Firm

12/29/2025 10:50 AM • The Schall Law Firm has filed a class action lawsuit against Firefly Aerospace Inc. (NASDAQ: FLY) for securities fraud, alleging the company made false and misleading statements during its August 2025 IPO. The complaint claims Firefly overstated growth potential and commercial viability of its Spacecraft Solutions business and Alpha rocket program. Investors who purchased securities during the class period are encouraged to join the lawsuit by January 12, 2026.

FLY - The company is the subject of a securities fraud lawsuit alleging material misstatements about its business growth potential and commercial viability. These allegations indicate serious corporate governance and disclosure violations that resulted in investor losses.

#securities fraud #class action lawsuit #IPO #false statements #Firefly Aerospace #shareholder rights

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • Schall Law Firm

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

12/29/2025 10:45 AM • The Schall Law Firm has filed a securities fraud class action lawsuit against Skye Bioscience, Inc. (NASDAQ: SKYE) for allegedly making false and misleading statements about its drug candidate nimacimab, overstating its commercial and clinical prospects. Investors who purchased securities between November 4, 2024 and October 3, 2025 are encouraged to join the lawsuit by January 16, 2026.

SKYE - The company is accused of making false and misleading statements about its drug candidate's effectiveness and overstating commercial and clinical prospects, resulting in investor losses when the truth was revealed to the market.

#securities fraud #class action lawsuit #Skye Bioscience #nimacimab #false statements #shareholder rights #investor losses

FRMI INVESTIGATION ALERT: Investigation Launched into Fermi Inc., RGRD Law Encourages Investors and Potential Witnesses to Contact Law Firm

GlobeNewswire Inc. • Robbins Geller Rudman & Dowd Llp

FRMI INVESTIGATION ALERT: Investigation Launched into Fermi Inc., RGRD Law Encourages Investors and Potential Witnesses to Contact Law Firm

12/29/2025 10:40 AM • Robbins Geller Rudman & Dowd LLP has launched an investigation into Fermi Inc. for potential securities law violations related to false or misleading statements. The investigation was triggered after Fermi's major tenant terminated a $150 million construction funding agreement in December 2025, causing the stock to plummet 33% from its $21 IPO price to $10.09.

BERZ - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
FRMI - Major tenant terminated a critical $150 million construction funding agreement, stock fell 33% below IPO price, and the company is under investigation for potential securities law violations involving false or misleading statements to investors.

#securities fraud investigation #IPO #false statements #material information #stock price decline #tenant termination #construction funding

GlobeNewswire Inc. • Na

Form 8.3 - Empiric Student Property Plc

12/29/2025 09:58 AM • Rathbones Group Plc has disclosed a 2.77% interest in Empiric Student Property Plc, comprising 18,456,582 ordinary shares. The disclosure was made following a sale of 49,960 shares at 76.52p per share on 24/12/2025, as required under Rule 8.3 of the Takeover Code.

STRC - Shares declined for fourth straight session to lowest level in over a year
EPRCY - Subject of a standard disclosure filing indicating a significant shareholder position. The disclosure itself is procedural and does not convey positive or negative sentiment about the company's prospects.

#stake disclosure #Takeover Code #Rule 8.3 #share sale #relevant securities #public opening position disclosure

Portnoy Law Firm Announces Class Action on Behalf of DeFi Technologies, Inc. Investors

GlobeNewswire Inc. • Portnoy Law Firm

Portnoy Law Firm Announces Class Action on Behalf of DeFi Technologies, Inc. Investors

12/29/2025 09:51 AM • The Portnoy Law Firm has announced a class action lawsuit on behalf of DeFi Technologies investors who purchased securities between May 12, 2025 and November 14, 2025. The lawsuit alleges that DeFi Technologies made false and misleading statements regarding delays in executing its DeFi arbitrage strategy, understated competition from digital asset treasury companies, and failed to meet its 2025 revenue guidance. Investors have until January 30, 2026 to file a lead plaintiff motion.

STRD - Shares declined for fourth straight session to lowest level in over a year
DEFT - The company is the subject of a securities fraud class action lawsuit alleging material misstatements about its core DeFi arbitrage strategy, competitive position, and inability to meet revenue guidance. These allegations indicate serious operational and disclosure failures that resulted in investor losses.

#class action lawsuit #DeFi Technologies #securities fraud #false statements #revenue guidance #DeFi arbitrage strategy #investor losses

KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law Firm

12/29/2025 09:50 AM • The Schall Law Firm is seeking investors who purchased CarMax securities between June 20, 2025 and September 24, 2025 to join a class action lawsuit alleging securities fraud. CarMax allegedly made false and misleading statements by overstating growth prospects, with actual growth driven by customer speculation about vehicle tariffs rather than genuine business performance.

STRF - Shares declined for fourth straight session to lowest level in over a year
KMX - The company is accused of making false and misleading statements about growth prospects, with actual growth artificially inflated by tariff speculation rather than genuine business fundamentals. This resulted in investor losses and triggered a securities fraud lawsuit.

#securities fraud #class action lawsuit #CarMax #false statements #investor losses #tariff speculation

Portnoy Law Firm Announces Class Action on Behalf of BitDeer Technologies Group Investors

GlobeNewswire Inc. • Portnoy Law Firm

Portnoy Law Firm Announces Class Action on Behalf of BitDeer Technologies Group Investors

12/29/2025 09:49 AM • The Portnoy Law Firm has announced a class action lawsuit on behalf of BitDeer Technologies Group investors who purchased securities between June 6, 2024 and November 10, 2025. The lawsuit was triggered after BitDeer reported significantly worse-than-expected Q3 2025 earnings (EPS of -$1.28 vs. consensus of -$0.22) and disclosed major delays in its next-generation Seal 04 ASIC chip development. The stock fell 14.9% on the news.

STRK - Shares declined for fourth straight session to lowest level in over a year
BTDR - Company significantly missed earnings expectations (EPS of -$1.28 vs. -$0.22 consensus), disclosed major delays in critical next-generation chip development, and experienced a 14.9% stock price decline, triggering a class action lawsuit for investor losses.

#class action lawsuit #BitDeer Technologies #missed earnings #ASIC chip delay #stock decline #investor losses

Portnoy Law Firm Announces Class Action on Behalf of Avantor, Inc. Investors

GlobeNewswire Inc. • Portnoy Law Firm

Portnoy Law Firm Announces Class Action on Behalf of Avantor, Inc. Investors

12/29/2025 09:45 AM • Avantor, Inc. faces a class action lawsuit alleging that company executives failed to disclose weakening competitive positioning and increased competitive intensity affecting its Laboratory Solutions business. The company cut guidance multiple times in 2025 after reporting weak organic sales growth. Stock prices fell significantly following each earnings announcement (16%, 15%, and 23% declines), with the third quarter results revealing that actual performance was worse than management's recent projections.

AVTR - The company is facing a class action lawsuit for allegedly failing to disclose weakening competitive positioning. Multiple guidance cuts throughout 2025, significant stock price declines following earnings announcements, and management admissions of increased competitive intensity and reduced customer volumes indicate serious operational and financial deterioration.

#class action lawsuit #securities fraud #competitive intensity #guidance cuts #Laboratory Solutions #organic sales decline #stock price decline #disclosure failure

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

GlobeNewswire Inc. • Na

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

12/29/2025 09:00 AM • Nutriband Inc. announced the sale of a 90% stake in its subsidiary Pocono Pharmaceutical to EarthVision Bio for $5 million USD, with Nutriband shareholders retaining 10% ownership. The company plans to use proceeds to develop AVERSA Fentanyl, an abuse-deterrent opioid patch with potential annual US sales of $80-200 million. EarthVision Bio is developing sustainable product alternatives founded by Intel co-founder Dr. Gordon Moore and ex-Chevron Europe chairman Dr. Hans Franke.

NTRB - Company is raising capital ($5M) to fund development of its lead product AVERSA Fentanyl with significant market potential ($80-200M annual sales). The divestment of non-core subsidiary allows focus on higher-value pharmaceutical development. Retention of 10% stake in EarthVision Bio provides upside participation.

#asset sale #subsidiary divestment #abuse-deterrent fentanyl #transdermal pharmaceutical #sustainable products #opioid innovation